KathleenMaryGrimaMD

PubMed

• 4 citations
  The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention.
  Debra Kessler, Kathleen Grima, Jay E. Valinsky, Caroline Ortiz, Christopher D. Hillyer, Vijay Nandi, Robert L. Jones, Beth H. Shaz> ;Transfusion and Apheresis Science. 2013 Oct 1
• 10 citations
  Cardiovascular disease risk assessment and prevention in blood donors.
  Debra Kessler, Caroline Ortiz, Kathleen Grima, David Vlahov, Vijay Nandi, Robert S. Jones, Christopher D. Hillyer, Beth H. Shaz> ;Transfusion. 2012 Oct 1
• 8 citations
  Seroprevalence of Chagas Infection in the Donor Population
  Ben A. Zaniello, Deborah A. Kessler, Katherine M. Vine, Kathleen M. Grima, Scott A. Weisenberg> ;Plos Neglected Tropical Diseases. 2012 Jul 31
• 22 citations
  2-(Diethylhexyl)phthalate in blood bags: is this a public health issue?
  Beth H. Shaz, Kathleen Grima, Christopher D. Hillyer> ;Transfusion. 2011 Nov 1
• 79 citations
  ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies
  Cassandra D. Josephson, Marta-Inés Castillejo, Kathleen Grima, Christopher D. Hillyer> ;Transfusion and Apheresis Science. 2010 Feb 1
• 4 citations
  Severe hemolysis following administration of Rho(D) immune globulin in an ITP patient associated with anti-C
  Joseph E. Schwartz, Steve Spitalnik, Kathleen M. Grima> ;Blood. 2006 Mar 15
• 47 citations
  Exchange transfusion for malaria and Babesia infection.
  Vivien I. Powell, Kathleen Grima> ;Transfusion Medicine Reviews. 2002 Jul 1
• 33 citations
  Therapeutic apheresis in renal and metabolic diseases.
  Jeffrey L. Winters, Alvaro A. Pineda, Bruce C. McLeod, Kathleen M. Grima> ;Journal of Clinical Apheresis. 2000 Jan 1
• 46 citations
  Therapeutic apheresis in hematological and oncological diseases.
  Kathleen M. Grima> ;Journal of Clinical Apheresis. 2000 Jan 1
• Factors Influencing Prognosis after Dose‐Intensive Therapy for Recurrent or Refractory Hodgkin's Disease
  Tauseef Ahmed, D. E. Lake, Eric J. Feldman, Karen Seiter, L. Helson, Abraham Mittelman, C. Puccio, Hoo G. Chun, Kathleen Grima, Tanveer Akhtar, Jeffrey Perchick, Zubai...> ;Annals of the New York Academy of Sciences. 1995 Dec 1
• 35 citations
  Colonic ischemia complicating immunotherapy with interleukin‐2 and interferon‐alpha
  Joseph A. Sparano, Janice P. Dutcher, Ronald Kaleya, Geralyn Caliendo, Joseph Fiorito, Sumi Mitsudo, Richard Shechner, Scott J. Boley, Rasim Gucalp, Niculae Ciobanu, K...> ;Cancer. 1991 Oct 1
• 35 citations
  Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable M...
  Ellen R. Gaynor, Geoffrey R. Weiss, Kim Margolin, Frederick R. Aronson, Mario Sznol, Paul Demchak, Kathleen M. Grima, Richard I. Fisher, David H. Boldt, James H. Doros...> ;Journal of the National Cancer Institute. 1990 Sep 5
• Survival after phase II treatment of advanced renal cell carcinoma with taxol or high-dose interleukin-2.
  Walpole, E. T., Dutcher, J. P., Sparano, J., Gucalp, R., Einzig, A., Paietta, E., Ciobanu, N., Grima, K., Caliendo, G., Cavasotto, G.> ;J Immunother Emphasis Tumor Immunol. 1993 May 4
• GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes.
  Dancis, A., Ehmann, C., Ferziger, R., Grima, K., Karpatkin, S.> ;Blood. 1988 Apr
• Anti-HLA antibody removal by extracorporeal immunoadsorption in two hyperimmunized pediatric patients awaiting hepatointestinal transplantation.
  Tschernia, A., LeLeiko, N. S., Grima, K., Whittset, C., Molnar, K., Spencer, R. W., Sloves, M. F., Gondolesi, G., Kaufman, S. S., Fishbein, T. M.> ;Transplant Proc. 2002 May
• 34 citations
  Evaluation of solvent/detergent-treated plasma in patients with a prolonged prothrombin time.
  R.G. Lerner, J. Nelson, E. Sorcia, K. Grima, R.R. Kancherla, C.M. Zarou-Naimo, J.C. Pehta> ;Vox Sanguinis. 2000 Nov 1
• Join now to see all